Dr. Mark Socinski, international leader in the field of lung cancer, from the University of North Carolina at Chapel Hill, gave a terrific presentation on timing and selection of treatment after the first line setting for advanced NSCLC.  In addition to the podcast of his presentation itself, here now is the question and answer session that followed it.

The Q&A portion includes slides with the questions as well as some slides that illustrate key points.  Below, you’ll find the audio and video versions of the podcast, the figures, and also the transcript of the program.

socinski-qa-session-maintenance-therapy-audio-podcast

socinski-qa-session-maintenance-therapy-figures

socinski-qa-session-maintenance-therapy-transcript

We are very grateful to Eli Lilly Oncology for the educational grant that supported this activity.  Eli Lilly had no input in the development of any of its content.

Podcast: Play in new window | Download

Related posts:

Podcast of Webinar by Dr. Lecia Sequist on Acquired Resistance to Oral EGFR Inhibitors A few weeks ago, Dr. Lecia Sequist, Assistant Professor of Medicine at Harvard Medica...

Q&A Session from Webinar with Dr. Lilenbaum on Managing Elderly Patients with Lung Cancer Following the excellent podcast by Dr. Rogerio Lilenbaum, lung cancer expert an...

ASCO Highlights in Lung Cancer Q&A Session ALERT: The links for the podcasts are now fixed. Here’s the question and answe...

ASCO Highlights in Advanced NSCLC, by Dr. Nasser Hanna Here’s the second talk from our recent webinar, partnering with LUNGevit...

Q&A on ALK Inhibitor Therapy, with Drs. Ben Solomon and Ross Camidge Following the terrific presentations by Drs. Ben Solomon and Ross Camidge on th...